These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12436621)

  • 1. [Detection of coronary reperfusion using biochemical markers].
    Ishii J; Nomura M
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):813-9. PubMed ID: 12436621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of coronary reperfusion using biochemical markers].
    Ishii J
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():473-8. PubMed ID: 12735018
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
    de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
    Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multi-maker strategy for diagnosis of acute coronary syndrome].
    Seino Y; Takano T
    Nihon Naika Gakkai Zasshi; 2004 Feb; 93(2):241-8. PubMed ID: 15007930
    [No Abstract]   [Full Text] [Related]  

  • 5. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome.
    Nakata T; Hashimoto A; Hase M; Tsuchihashi K; Shimamoto K
    Cardiology; 2003; 99(2):96-104. PubMed ID: 12711885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress on biochemical diagnosis of acute myocardial infarction].
    Tanaka H; Abe S
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1180-5. PubMed ID: 1431455
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients.
    Fransen EJ; Maessen JG; Hermens WT; Glatz JF
    Ann Thorac Surg; 1998 Jan; 65(1):48-53. PubMed ID: 9456094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Steg PG; Dehoux M; Benessiano J; Grollier G; Aliot E; Mossard JM; Aubry P; Coisne D; Hanssen M
    Circulation; 1995 Oct; 92(8):2079-86. PubMed ID: 7554185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
    de Lemos JA; Antman EM; Morrow DA; Llevadot J; Giugliano RP; Coulter SA; Schuhwerk KC; Arslanian S; McCabe CH; Gibson CM; Rifai N
    Clin Chim Acta; 2000 Aug; 298(1-2):85-97. PubMed ID: 10876006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of early reperfusion.
    Grande P; Clemmensen P; Ohman EM; Wagner GS
    J Electrocardiol; 1992; 25 Suppl():6-9. PubMed ID: 1297710
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction.
    Ghani F; Wu AH; Graff L; Petry C; Armstrong G; Prigent F; Brown M
    Clin Chem; 2000 May; 46(5):718-9. PubMed ID: 10794758
    [No Abstract]   [Full Text] [Related]  

  • 13. Using newer cardiac markers.
    Tasota FJ; Tate J
    Nursing; 2000 Dec; 30(12):28. PubMed ID: 11249430
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.
    Wodzig KW; Kragten JA; Modrzejewski W; Górski J; van Dieijen-Visser MP; Glatz JF; Hermens WT
    Clin Chim Acta; 1998 Apr; 272(2):209-23. PubMed ID: 9641361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical diagnosis of acute coronary ischemia].
    Galán Ortega A
    Med Clin (Barc); 2000 Nov; 115(17):671-6. PubMed ID: 11141419
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting.
    Petzold T; Feindt P; Sunderdiek U; Boeken U; Fischer Y; Gams E
    Eur J Cardiothorac Surg; 2001 Jun; 19(6):859-64. PubMed ID: 11404143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of renal function on serum and urinary heart fatty acid-binding protein levels.
    Nayashida N; Chihara S; Tayama E; Akasu K; Kai E; Kawara T; Aoyagi S
    J Cardiovasc Surg (Torino); 2001 Dec; 42(6):735-40. PubMed ID: 11698938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction.
    Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K
    Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of ischemic and non-ischemic myocardial damage].
    Herrmann J; Volbracht L; Haude M; Eggebrecht H; Malyar N; Mann K; Erbel R
    Med Klin (Munich); 2001 Mar; 96(3):144-56. PubMed ID: 11315398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid-binding protein as marker of muscle injury: experimental findings and clinical application.
    Glatz JF; Van der Vusse GJ; Maessen JG; Van Dieijen-Visser MP; Hermens WT
    Acta Anaesthesiol Scand Suppl; 1997; 111():292-4. PubMed ID: 9421050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.